Effects of Laser Therapy on Muscle Function in COPD Patients (LTCOPD)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01448564|
Recruitment Status : Unknown
Verified September 2013 by Eduardo Foschini Miranda, University of Nove de Julho.
Recruitment status was: Recruiting
First Posted : October 7, 2011
Last Update Posted : September 4, 2013
|Condition or disease||Intervention/treatment||Phase|
|Chronic Obstructive Pulmonary Disease Fatigue||Other: Laser therapy Other: Placebo laser therapy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||27 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||Effects of Light-emitting Diodes (LED) on Peripheral Muscle Function, Exercise Tolerance and Cardiorespiratory Response During Exercise in Patients With Chronic Obstructive Pulmonary Disease|
|Study Start Date :||June 2012|
|Primary Completion Date :||December 2013|
|Study Completion Date :||December 2013|
Active Comparator: Laser therapy
Recently has been using the LED, known by its acronym in English LED (Light Emitting Diode), devices that are light-emitting non-coherent and monochromatic, having a longer wavelength (± 10 - 30 nm) compared to lasers. The difference between the fundamental radiation emitted by a laser and an LED is the coherence of the beam.
Other: Laser therapy
The therapeutic effects of low intensity lasers are: (i) analgesic and anti-inflammatory, (ii) regeneration, (iii) tissue healing and (vi) recovery from muscle fatigue.
Other Name: (Light Emitting Diode)
|Placebo Comparator: Placebo Laser therapy||
Other: Placebo laser therapy
The application of laser therapy will be a low intensity laser.
- Analysis of the recovery time for the isometric and dynamic protocol [ Time Frame: Measures muscular endurance will be compared after a period of 1 week. ]
- Analysis of lactate levels and the activity of CK and C-reactive protein (CRP). [ Time Frame: Measures blood will be compared after a period of 1 week. ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01448564
|Contact: Eduardo Miranda||05511 firstname.lastname@example.org|
|Contact: Simone Dal Corso||05511 email@example.com|
|University Nove de Julho||Recruiting|
|São Paulo, Brazil|
|Contact: Eduardo F Miranda, physiotherapist 05511 36659748 firstname.lastname@example.org|
|Contact: Simone D Corso, physiotherapist 05511 36659758 email@example.com|
|Principal Investigator: Eduardo F Miranda, physiotherapist|
|Principal Investigator:||Eduardo Miranda|